Arcturus Therapeutics Holdings Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of ARCT for the last quarter is 38.81 M USD, and it's 15.58% lower compared to the previous quarter. The net income of Q3 24 is -6.90 M USD.